Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Healthcare Nanotechnology Revenue 1.4 Market Analysis by Type 1.4.1 Global Healthcare Nanotechnology Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Nanomedicine 1.4.3 Nano Medical Devices 1.4.4 Nano Diagnosis 1.4.5 Others 1.5 Market by Application 1.5.1 Global Healthcare Nanotechnology Market Share by Application: 2020 VS 2026 1.5.2 Anticancer 1.5.3 CNS Product 1.5.4 Anti-infective 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Healthcare Nanotechnology Market Perspective (2015-2026) 2.2 Healthcare Nanotechnology Growth Trends by Regions 2.2.1 Healthcare Nanotechnology Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Healthcare Nanotechnology Historic Market Share by Regions (2015-2020) 2.2.3 Healthcare Nanotechnology Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Healthcare Nanotechnology Market Growth Strategy 2.3.6 Primary Interviews with Key Healthcare Nanotechnology Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Healthcare Nanotechnology Players by Market Size 3.1.1 Global Top Healthcare Nanotechnology Players by Revenue (2015-2020) 3.1.2 Global Healthcare Nanotechnology Revenue Market Share by Players (2015-2020) 3.1.3 Global Healthcare Nanotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Healthcare Nanotechnology Market Concentration Ratio 3.2.1 Global Healthcare Nanotechnology Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Healthcare Nanotechnology Revenue in 2019 3.3 Healthcare Nanotechnology Key Players Head office and Area Served 3.4 Key Players Healthcare Nanotechnology Product Solution and Service 3.5 Date of Enter into Healthcare Nanotechnology Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Healthcare Nanotechnology Historic Market Size by Type (2015-2020) 4.2 Global Healthcare Nanotechnology Forecasted Market Size by Type (2021-2026) 5 Healthcare Nanotechnology Breakdown Data by Application (2015-2026) 5.1 Global Healthcare Nanotechnology Market Size by Application (2015-2020) 5.2 Global Healthcare Nanotechnology Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Healthcare Nanotechnology Market Size (2015-2020) 6.2 Healthcare Nanotechnology Key Players in North America (2019-2020) 6.3 North America Healthcare Nanotechnology Market Size by Type (2015-2020) 6.4 North America Healthcare Nanotechnology Market Size by Application (2015-2020) 7 Europe 7.1 Europe Healthcare Nanotechnology Market Size (2015-2020) 7.2 Healthcare Nanotechnology Key Players in Europe (2019-2020) 7.3 Europe Healthcare Nanotechnology Market Size by Type (2015-2020) 7.4 Europe Healthcare Nanotechnology Market Size by Application (2015-2020) 8 China 8.1 China Healthcare Nanotechnology Market Size (2015-2020) 8.2 Healthcare Nanotechnology Key Players in China (2019-2020) 8.3 China Healthcare Nanotechnology Market Size by Type (2015-2020) 8.4 China Healthcare Nanotechnology Market Size by Application (2015-2020) 9 Japan 9.1 Japan Healthcare Nanotechnology Market Size (2015-2020) 9.2 Healthcare Nanotechnology Key Players in Japan (2019-2020) 9.3 Japan Healthcare Nanotechnology Market Size by Type (2015-2020) 9.4 Japan Healthcare Nanotechnology Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Healthcare Nanotechnology Market Size (2015-2020) 10.2 Healthcare Nanotechnology Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Healthcare Nanotechnology Market Size by Type (2015-2020) 10.4 Southeast Asia Healthcare Nanotechnology Market Size by Application (2015-2020) 11 India 11.1 India Healthcare Nanotechnology Market Size (2015-2020) 11.2 Healthcare Nanotechnology Key Players in India (2019-2020) 11.3 India Healthcare Nanotechnology Market Size by Type (2015-2020) 11.4 India Healthcare Nanotechnology Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Healthcare Nanotechnology Market Size (2015-2020) 12.2 Healthcare Nanotechnology Key Players in Central & South America (2019-2020) 12.3 Central & South America Healthcare Nanotechnology Market Size by Type (2015-2020) 12.4 Central & South America Healthcare Nanotechnology Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Amgen 13.1.1 Amgen Company Details 13.1.2 Amgen Business Overview and Its Total Revenue 13.1.3 Amgen Healthcare Nanotechnology Introduction 13.1.4 Amgen Revenue in Healthcare Nanotechnology Business (2015-2020)) 13.1.5 Amgen Recent Development 13.2 Teva Pharmaceuticals 13.2.1 Teva Pharmaceuticals Company Details 13.2.2 Teva Pharmaceuticals Business Overview and Its Total Revenue 13.2.3 Teva Pharmaceuticals Healthcare Nanotechnology Introduction 13.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology Business (2015-2020) 13.2.5 Teva Pharmaceuticals Recent Development 13.3 Abbott 13.3.1 Abbott Company Details 13.3.2 Abbott Business Overview and Its Total Revenue 13.3.3 Abbott Healthcare Nanotechnology Introduction 13.3.4 Abbott Revenue in Healthcare Nanotechnology Business (2015-2020) 13.3.5 Abbott Recent Development 13.4 UCB 13.4.1 UCB Company Details 13.4.2 UCB Business Overview and Its Total Revenue 13.4.3 UCB Healthcare Nanotechnology Introduction 13.4.4 UCB Revenue in Healthcare Nanotechnology Business (2015-2020) 13.4.5 UCB Recent Development 13.5 Roche 13.5.1 Roche Company Details 13.5.2 Roche Business Overview and Its Total Revenue 13.5.3 Roche Healthcare Nanotechnology Introduction 13.5.4 Roche Revenue in Healthcare Nanotechnology Business (2015-2020) 13.5.5 Roche Recent Development 13.6 Celgene 13.6.1 Celgene Company Details 13.6.2 Celgene Business Overview and Its Total Revenue 13.6.3 Celgene Healthcare Nanotechnology Introduction 13.6.4 Celgene Revenue in Healthcare Nanotechnology Business (2015-2020) 13.6.5 Celgene Recent Development 13.7 Sanofi 13.7.1 Sanofi Company Details 13.7.2 Sanofi Business Overview and Its Total Revenue 13.7.3 Sanofi Healthcare Nanotechnology Introduction 13.7.4 Sanofi Revenue in Healthcare Nanotechnology Business (2015-2020) 13.7.5 Sanofi Recent Development 13.8 Merck & Co 13.8.1 Merck & Co Company Details 13.8.2 Merck & Co Business Overview and Its Total Revenue 13.8.3 Merck & Co Healthcare Nanotechnology Introduction 13.8.4 Merck & Co Revenue in Healthcare Nanotechnology Business (2015-2020) 13.8.5 Merck & Co Recent Development 13.9 Biogen 13.9.1 Biogen Company Details 13.9.2 Biogen Business Overview and Its Total Revenue 13.9.3 Biogen Healthcare Nanotechnology Introduction 13.9.4 Biogen Revenue in Healthcare Nanotechnology Business (2015-2020) 13.9.5 Biogen Recent Development 13.10 Stryker 13.10.1 Stryker Company Details 13.10.2 Stryker Business Overview and Its Total Revenue 13.10.3 Stryker Healthcare Nanotechnology Introduction 13.10.4 Stryker Revenue in Healthcare Nanotechnology Business (2015-2020) 13.10.5 Stryker Recent Development 13.11 Gilead Sciences 10.11.1 Gilead Sciences Company Details 10.11.2 Gilead Sciences Business Overview and Its Total Revenue 10.11.3 Gilead Sciences Healthcare Nanotechnology Introduction 10.11.4 Gilead Sciences Revenue in Healthcare Nanotechnology Business (2015-2020) 10.11.5 Gilead Sciences Recent Development 13.12 Pfizer 10.12.1 Pfizer Company Details 10.12.2 Pfizer Business Overview and Its Total Revenue 10.12.3 Pfizer Healthcare Nanotechnology Introduction 10.12.4 Pfizer Revenue in Healthcare Nanotechnology Business (2015-2020) 10.12.5 Pfizer Recent Development 13.13 3M Company 10.13.1 3M Company Company Details 10.13.2 3M Company Business Overview and Its Total Revenue 10.13.3 3M Company Healthcare Nanotechnology Introduction 10.13.4 3M Company Revenue in Healthcare Nanotechnology Business (2015-2020) 10.13.5 3M Company Recent Development 13.14 Johnson & Johnson 10.14.1 Johnson & Johnson Company Details 10.14.2 Johnson & Johnson Business Overview and Its Total Revenue 10.14.3 Johnson & Johnson Healthcare Nanotechnology Introduction 10.14.4 Johnson & Johnson Revenue in Healthcare Nanotechnology Business (2015-2020) 10.14.5 Johnson & Johnson Recent Development 13.15 Smith & Nephew 10.15.1 Smith & Nephew Company Details 10.15.2 Smith & Nephew Business Overview and Its Total Revenue 10.15.3 Smith & Nephew Healthcare Nanotechnology Introduction 10.15.4 Smith & Nephew Revenue in Healthcare Nanotechnology Business (2015-2020) 10.15.5 Smith & Nephew Recent Development 13.16 Leadiant Biosciences 10.16.1 Leadiant Biosciences Company Details 10.16.2 Leadiant Biosciences Business Overview and Its Total Revenue 10.16.3 Leadiant Biosciences Healthcare Nanotechnology Introduction 10.16.4 Leadiant Biosciences Revenue in Healthcare Nanotechnology Business (2015-2020) 10.16.5 Leadiant Biosciences Recent Development 13.17 Kyowa Hakko Kirin 10.17.1 Kyowa Hakko Kirin Company Details 10.17.2 Kyowa Hakko Kirin Business Overview and Its Total Revenue 10.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology Introduction 10.17.4 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology Business (2015-2020) 10.17.5 Kyowa Hakko Kirin Recent Development 13.18 Takeda 10.18.1 Takeda Company Details 10.18.2 Takeda Business Overview and Its Total Revenue 10.18.3 Takeda Healthcare Nanotechnology Introduction 10.18.4 Takeda Revenue in Healthcare Nanotechnology Business (2015-2020) 10.18.5 Takeda Recent Development 13.19 Ipsen 10.19.1 Ipsen Company Details 10.19.2 Ipsen Business Overview and Its Total Revenue 10.19.3 Ipsen Healthcare Nanotechnology Introduction 10.19.4 Ipsen Revenue in Healthcare Nanotechnology Business (2015-2020) 10.19.5 Ipsen Recent Development 13.20 Endo International 10.20.1 Endo International Company Details 10.20.2 Endo International Business Overview and Its Total Revenue 10.20.3 Endo International Healthcare Nanotechnology Introduction 10.20.4 Endo International Revenue in Healthcare Nanotechnology Business (2015-2020) 10.20.5 Endo International Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Healthcare Nanotechnology Key Market Segments Table 2. Key Players Covered: Ranking by Healthcare Nanotechnology Revenue Table 3. Ranking of Global Top Healthcare Nanotechnology Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Healthcare Nanotechnology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Nanomedicine Table 6. Key Players of Nano Medical Devices Table 7. Key Players of Nano Diagnosis Table 8. Key Players of Others Table 9. Global Healthcare Nanotechnology Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Healthcare Nanotechnology Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Healthcare Nanotechnology Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Healthcare Nanotechnology Market Share by Regions (2015-2020) Table 13. Global Healthcare Nanotechnology Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Healthcare Nanotechnology Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Healthcare Nanotechnology Market Growth Strategy Table 19. Main Points Interviewed from Key Healthcare Nanotechnology Players Table 20. Global Healthcare Nanotechnology Revenue by Players (2015-2020) (Million US$) Table 21. Global Healthcare Nanotechnology Market Share by Players (2015-2020) Table 22. Global Top Healthcare Nanotechnology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare Nanotechnology as of 2019) Table 23. Global Healthcare Nanotechnology by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Healthcare Nanotechnology Product Solution and Service Table 26. Date of Enter into Healthcare Nanotechnology Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 29. Global Healthcare Nanotechnology Market Size Share by Type (2015-2020) Table 30. Global Healthcare Nanotechnology Revenue Market Share by Type (2021-2026) Table 31. Global Healthcare Nanotechnology Market Size Share by Application (2015-2020) Table 32. Global Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 33. Global Healthcare Nanotechnology Market Size Share by Application (2021-2026) Table 34. North America Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 35. North America Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 36. North America Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 37. North America Healthcare Nanotechnology Market Share by Type (2015-2020) Table 38. North America Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 39. North America Healthcare Nanotechnology Market Share by Application (2015-2020) Table 40. Europe Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 42. Europe Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 43. Europe Healthcare Nanotechnology Market Share by Type (2015-2020) Table 44. Europe Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 45. Europe Healthcare Nanotechnology Market Share by Application (2015-2020) Table 46. China Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 47. China Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 48. China Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 49. China Healthcare Nanotechnology Market Share by Type (2015-2020) Table 50. China Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 51. China Healthcare Nanotechnology Market Share by Application (2015-2020) Table 52. Japan Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 54. Japan Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 55. Japan Healthcare Nanotechnology Market Share by Type (2015-2020) Table 56. Japan Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 57. Japan Healthcare Nanotechnology Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 60. Southeast Asia Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Healthcare Nanotechnology Market Share by Type (2015-2020) Table 62. Southeast Asia Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Healthcare Nanotechnology Market Share by Application (2015-2020) Table 64. India Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 65. India Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 66. India Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 67. India Healthcare Nanotechnology Market Share by Type (2015-2020) Table 68. India Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 69. India Healthcare Nanotechnology Market Share by Application (2015-2020) Table 70. Central & South America Key Players Healthcare Nanotechnology Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Healthcare Nanotechnology Market Share (2019-2020) Table 72. Central & South America Healthcare Nanotechnology Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Healthcare Nanotechnology Market Share by Type (2015-2020) Table 74. Central & South America Healthcare Nanotechnology Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Healthcare Nanotechnology Market Share by Application (2015-2020) Table 76. Amgen Company Details Table 77. Amgen Business Overview Table 78. Amgen Product Table 79. Amgen Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 80. Amgen Recent Development Table 81. Teva Pharmaceuticals Company Details Table 82. Teva Pharmaceuticals Business Overview Table 83. Teva Pharmaceuticals Product Table 84. Teva Pharmaceuticals Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 85. Teva Pharmaceuticals Recent Development Table 86. Abbott Company Details Table 87. Abbott Business Overview Table 88. Abbott Product Table 89. Abbott Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 90. Abbott Recent Development Table 91. UCB Company Details Table 92. UCB Business Overview Table 93. UCB Product Table 94. UCB Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 95. UCB Recent Development Table 96. Roche Company Details Table 97. Roche Business Overview Table 98. Roche Product Table 99. Roche Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 100. Roche Recent Development Table 101. Celgene Company Details Table 102. Celgene Business Overview Table 103. Celgene Product Table 104. Celgene Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 105. Celgene Recent Development Table 106. Sanofi Company Details Table 107. Sanofi Business Overview Table 108. Sanofi Product Table 109. Sanofi Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 110. Sanofi Recent Development Table 111. Merck & Co Business Overview Table 112. Merck & Co Product Table 113. Merck & Co Company Details Table 114. Merck & Co Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 115. Merck & Co Recent Development Table 116. Biogen Company Details Table 117. Biogen Business Overview Table 118. Biogen Product Table 119. Biogen Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 120. Biogen Recent Development Table 121. Stryker Company Details Table 122. Stryker Business Overview Table 123. Stryker Product Table 124. Stryker Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 125. Stryker Recent Development Table 126. Gilead Sciences Company Details Table 127. Gilead Sciences Business Overview Table 128. Gilead Sciences Product Table 129. Gilead Sciences Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 130. Gilead Sciences Recent Development Table 131. Pfizer Company Details Table 132. Pfizer Business Overview Table 133. Pfizer Product Table 134. Pfizer Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 135. Pfizer Recent Development Table 136. 3M Company Company Details Table 137. 3M Company Business Overview Table 138. 3M Company Product Table 139. 3M Company Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 140. 3M Company Recent Development Table 141. Johnson & Johnson Company Details Table 142. Johnson & Johnson Business Overview Table 143. Johnson & Johnson Product Table 144. Johnson & Johnson Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 145. Johnson & Johnson Recent Development Table 146. Smith & Nephew Company Details Table 147. Smith & Nephew Business Overview Table 148. Smith & Nephew Product Table 149. Smith & Nephew Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 150. Smith & Nephew Recent Development Table 151. Leadiant Biosciences Company Details Table 152. Leadiant Biosciences Business Overview Table 153. Leadiant Biosciences Product Table 154. Leadiant Biosciences Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 155. Leadiant Biosciences Recent Development Table 156. Kyowa Hakko Kirin Company Details Table 157. Kyowa Hakko Kirin Business Overview Table 158. Kyowa Hakko Kirin Product Table 159. Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 160. Kyowa Hakko Kirin Recent Development Table 161. Takeda Company Details Table 162. Takeda Business Overview Table 163. Takeda Product Table 164. Takeda Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 165. Takeda Recent Development Table 166. Ipsen Company Details Table 167. Ipsen Business Overview Table 168. Ipsen Product Table 169. Ipsen Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 170. Ipsen Recent Development Table 171. Endo International Company Details Table 172. Endo International Business Overview Table 173. Endo International Product Table 174. Endo International Revenue in Healthcare Nanotechnology Business (2015-2020) (Million US$) Table 175. Endo International Recent Development Table 176. Research Programs/Design for This Report Table 177. Key Data Information from Secondary Sources Table 178. Key Data Information from Primary Sources List of Figures Figure 1. Global Healthcare Nanotechnology Market Share by Type: 2020 VS 2026 Figure 2. Nanomedicine Features Figure 3. Nano Medical Devices Features Figure 4. Nano Diagnosis Features Figure 5. Others Features Figure 6. Global Healthcare Nanotechnology Market Share by Application: 2020 VS 2026 Figure 7. Anticancer Case Studies Figure 8. CNS Product Case Studies Figure 9. Anti-infective Case Studies Figure 10. Others Case Studies Figure 11. Healthcare Nanotechnology Report Years Considered Figure 12. Global Healthcare Nanotechnology Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Healthcare Nanotechnology Market Share by Regions: 2020 VS 2026 Figure 14. Global Healthcare Nanotechnology Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Healthcare Nanotechnology Market Share by Players in 2019 Figure 17. Global Top Healthcare Nanotechnology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare Nanotechnology as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Healthcare Nanotechnology Revenue in 2019 Figure 19. North America Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Healthcare Nanotechnology Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Amgen Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 28. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Teva Pharmaceuticals Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 30. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Abbott Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 32. UCB Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. UCB Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 34. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Roche Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 36. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Celgene Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 38. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Sanofi Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 40. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Merck & Co Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 42. Biogen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Biogen Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 44. Stryker Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Stryker Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 46. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Gilead Sciences Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Pfizer Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 50. 3M Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. 3M Company Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Johnson & Johnson Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 54. Smith & Nephew Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. Smith & Nephew Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 56. Leadiant Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Leadiant Biosciences Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 58. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 59. Kyowa Hakko Kirin Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 60. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 61. Takeda Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 62. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 63. Ipsen Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 64. Endo International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 65. Endo International Revenue Growth Rate in Healthcare Nanotechnology Business (2015-2020) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Amgen Teva Pharmaceuticals Abbott UCB Roche Celgene Sanofi Merck & Co Biogen Stryker Gilead Sciences Pfizer 3M Company Johnson & Johnson Smith & Nephew Leadiant Biosciences Kyowa Hakko Kirin Takeda Ipsen Endo International